Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donald J Rogier is active.

Publication


Featured researches published by Donald J Rogier.


Archive | 1995

Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions

John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S Carter


Archive | 2006

Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors

Andrew Simon Bell; David Brown; David L. Brown; Yvette M. Fobian; John N. Freskos; Steven E. Heasley; Robert O. Hughes; Eric Jon Jacobsen; Brent V. Mischke; John M. Molyneaux; Joseph B. Moon; Dafydd R. Owen; Michael John Palmer; Christopher Phillips; Donald J Rogier; John K. Walker; Todd Michael Maddux; Michael B. Tollefson


Archive | 1997

Substituierte Benzensulfonamid-Derivate als Wirkstoff-Vorläufer von COX-2 Inhibitoren

James W. Malecha; Thomas D. Penning; Ish K. Khanna; Xiangdong Xu; Richard M. Weier; John J. Talley; Stephen R Bertenshaw; Matthew J. Graneto; Jeffrey S Carter; Jinglin Li; Srinivasan Nagarajan; David L. Brown; Donald J Rogier


Archive | 2007

Pyridine [3,4-b] pyrazinonen.

David L. Brown; Eric Jon Jacobsen; Andrew Simon Bell; Todd Michael Maddux; Michael B. Tollefson; Michael John Palmer; David Brown; Christopher Phillips; Robert O. Hughes; Dafydd R. Owen; Yvette M. Fobian; John N. Freskos; Steven E. Heasley; Brent V. Mischke; John M. Molyneaux; Joseph B. Moon; John K. Walker; Donald J Rogier


Archive | 2006

Composes de pyridine [3 , 4-b] pyrazinones utilises comme inhibiteurs de pde-5

Andrew Simon Bell; David Brown; David L. Brown; Yvette M. Fobian; John N. Freskos; Steven E. Heasley; Robert O. Hughes; Eric Jon Jacobsen; Brent V. Mischke; John M. Molyneaux; Joseph B. Moon; Dafydd R. Owen; Michael John Palmer; Christopher Phillips; Donald J Rogier; John K. Walker; Todd Michael Maddux; Michael B. Tollefson


Archive | 2006

Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors

Andrew Simon Bell; Alan G. Benson; David Brown; David L. Brown; Yvette M. Fobian; John N. Freskos; Steven E. Heasley; Robert O. Hughes; Eric Jon Jacobsen; Brent V. Mischke; John M. Molyneaux; Joseph B. Moon; Dafydd R. Owen; Michael John Palmer; Christopher Phillips; Donald J Rogier; John K. Walker; Todd Michael Maddux; Michael B. Tollefson


Archive | 2000

Asendatud bensopüraani derivaadid põletiku raviks

David L. Brown; Jeffery S Carter; Mark G. Obukowicz; Balekudru Devadas; John J. Talley; Matthew J. Graneto; Stephen R Bertenshaw; Donald J Rogier; Srinivasan Nagarajan; Cathleen E. Hanau; Susan J. Hartmann; Cindy L. Ludwig; Suzanne Metz


Archive | 1999

Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid

David L. Brown; John J. Talley; James W. Malecha; Stephen R Bertenshaw; Matthew J. Graneto; Jeffery S Carter; Jinglin Li; Srinivasan Nagarajan; Donald J Rogier; Thomas D. Penning; Ish K. Khanna; Xiangdong Xu; Richard M. Weier


Archive | 1999

Analogues substitues de benzopyranne pour le traitement de l'inflammation

Jeffrey S Carter; Balekudru Devadas; John J. Talley; David L. Brown; Matthew J. Graneto; Donald J Rogier; Srinivasan Nagarajan; Cathleen E. Hanau; Susan J. Hartmann; Cindy L. Ludwig; Suzanne Metz; Donald E. Korte; Stephen R Bertenshaw; Mark G. Obukowicz


Archive | 1998

Derives de benzopyrannes substitues pour le traitement de l'inflammation

Stephen R Bertenshaw; David L. Brown; Jeffery S Carter; Balekudru Devadas; Matthew J. Graneto; Cathleen E. Hanau; Susan J. Hartmann; Cindy L. Ludwig; Suzanne Metz; Srinivasan Nagarajan; Mark G. Obukowicz; Donald J Rogier; John J. Talley

Collaboration


Dive into the Donald J Rogier's collaboration.

Researchain Logo
Decentralizing Knowledge